A subcutaneous implantable cardioverter-defibrillator (S-ICD) implantation in infection high-risk patient - a case study.
Michał Kowara 1, 2  
,  
Marcin Grabowski 4  
,  
Joachim Winter 5  
,  
 
 
More details
Hide details
1
1st Department of Cardiology Medical University of Warsaw Ul. Banacha 1a, 02-097 Warsaw
2
Department of Experimental and Clinical Physiology Medical University of Warsaw Ul. Banacha 1b, 02-097 Warsaw
3
1st Department of Cardiology, Medical University of Warsaw Ul. Banacha 1a, 02-097 Warsaw
4
1st Department of Cardiology, Medical University of Warsaw, Ul. Banacha 1a, 02-097 Warsaw
5
Division of Cardiac Surgery, University of Düsseldorf, Moorenstrasse 5, 40225 Düsseldorf, Germany.
Publish date: 2017-11-21
 
Heart Beat 2017;2:15–18
KEYWORDS:
TOPICS:
ABSTRACT:
The cardiac device related infective endocarditis (CDRIE) is an important indication for the implantable cardiac device extraction. In patients after recovery from CDRIE, who present indication for implantable cardioverter-defibrilator (ICD) but without necessity for pacing therapy the subcutaneous ICD (S-ICD) seems to be a reasonable alternative. Here we present a patient with CRT-D device transferred to our hospital with the diagnosis of CDRIE and many comorbidities. The patient presented increased inflammatory markers serum level during the entire period of hospitalization, after device explanation and termination of antibiotic therapy. The blood culture tests were negative and transesophageal echocardiography showed no sign of endocarditis, therefore despite inflammatory biomarkers the patient has been implanted with S-ICD.
CORRESPONDING AUTHOR:
Michał Kowara   
1st Department of Cardiology Medical University of Warsaw Ul. Banacha 1a, 02-097 Warsaw, Banacha 1a, 02-097 Warszawa, Poland
eISSN:2543-6333